Global Celiac Drugs Market Research Report 2024(Status and Outlook)
Report Overview
Celiac disease is a chronic autoimmune disorder triggered by the ingestion of gluten-containing foods in genetically predisposed individuals. The disease causes damage to the small intestine, leading to malabsorption of nutrients. Celiac drugs are pharmaceutical products designed to manage the symptoms and complications of celiac disease, such as gluten-induced inflammation and intestinal damage.
The current market size for celiac drugs in 2023 is estimated at USD 250 million. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.50% from 2024 to 2032. Key growth drivers for the celiac drugs market include the increasing prevalence of celiac disease worldwide, growing awareness about gluten-related disorders, and advancements in drug development technologies.
One significant trend in the celiac drugs market is the rise in research and development activities focused on novel drug formulations and therapies for celiac disease. For example, there is ongoing research on enzyme supplements that could help individuals with celiac disease digest gluten more effectively. Another trend is the increasing adoption of gluten-free diets, leading to a higher demand for drugs that can alleviate symptoms in case of accidental gluten exposure.
Moreover, the market is witnessing a shift towards personalized medicine, where treatments are tailored to individual genetic profiles and disease characteristics. This trend is driven by advancements in genetic testing and precision medicine approaches, allowing for more targeted and effective celiac drug therapies.
In terms of regional market distribution, North America and Europe currently lead the celiac drugs market due to higher awareness levels, better healthcare infrastructure, and a larger patient pool. These regions also have well-established regulatory frameworks that support the development and commercialization of celiac drugs. In contrast, emerging markets in Asia-Pacific and Latin America are expected to experience significant growth due to improving healthcare access, rising disposable incomes, and increasing diagnosis rates of celiac disease.
Despite the market's growth prospects, several challenges need to be addressed. These include the high cost of celiac drugs, limited treatment options, varying regulatory standards across regions, and the need for more accurate diagnostic tools to identify celiac disease patients promptly. Overcoming these challenges will require collaboration among pharmaceutical companies, healthcare providers, and regulatory bodies to ensure the development of safe, effective, and affordable celiac drugs for patients worldwide.
This report provides a deep insight into the global Celiac Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celiac Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celiac Drugs market in any manner.
Global Celiac Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
Market Segmentation (by Type)
First Line Of Treatment
Second Line Of Treatment
Market Segmentation (by Application)
Men
Women
Children
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celiac Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Celiac disease is a chronic autoimmune disorder triggered by the ingestion of gluten-containing foods in genetically predisposed individuals. The disease causes damage to the small intestine, leading to malabsorption of nutrients. Celiac drugs are pharmaceutical products designed to manage the symptoms and complications of celiac disease, such as gluten-induced inflammation and intestinal damage.
The current market size for celiac drugs in 2023 is estimated at USD 250 million. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.50% from 2024 to 2032. Key growth drivers for the celiac drugs market include the increasing prevalence of celiac disease worldwide, growing awareness about gluten-related disorders, and advancements in drug development technologies.
One significant trend in the celiac drugs market is the rise in research and development activities focused on novel drug formulations and therapies for celiac disease. For example, there is ongoing research on enzyme supplements that could help individuals with celiac disease digest gluten more effectively. Another trend is the increasing adoption of gluten-free diets, leading to a higher demand for drugs that can alleviate symptoms in case of accidental gluten exposure.
Moreover, the market is witnessing a shift towards personalized medicine, where treatments are tailored to individual genetic profiles and disease characteristics. This trend is driven by advancements in genetic testing and precision medicine approaches, allowing for more targeted and effective celiac drug therapies.
In terms of regional market distribution, North America and Europe currently lead the celiac drugs market due to higher awareness levels, better healthcare infrastructure, and a larger patient pool. These regions also have well-established regulatory frameworks that support the development and commercialization of celiac drugs. In contrast, emerging markets in Asia-Pacific and Latin America are expected to experience significant growth due to improving healthcare access, rising disposable incomes, and increasing diagnosis rates of celiac disease.
Despite the market's growth prospects, several challenges need to be addressed. These include the high cost of celiac drugs, limited treatment options, varying regulatory standards across regions, and the need for more accurate diagnostic tools to identify celiac disease patients promptly. Overcoming these challenges will require collaboration among pharmaceutical companies, healthcare providers, and regulatory bodies to ensure the development of safe, effective, and affordable celiac drugs for patients worldwide.
This report provides a deep insight into the global Celiac Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Celiac Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Celiac Drugs market in any manner.
Global Celiac Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
Market Segmentation (by Type)
First Line Of Treatment
Second Line Of Treatment
Market Segmentation (by Application)
Men
Women
Children
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Celiac Drugs Market
- Overview of the regional outlook of the Celiac Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Celiac Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Celiac Drugs
1.2 Key Market Segments
1.2.1 Celiac Drugs Segment by Type
1.2.2 Celiac Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELIAC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celiac Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Celiac Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 CELIAC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Celiac Drugs Sales by Manufacturers (2019-2024)
3.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celiac Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celiac Drugs Sales Sites, Area Served, Product Type
3.6 Celiac Drugs Market Competitive Situation and Trends
3.6.1 Celiac Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celiac Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELIAC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Celiac Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELIAC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELIAC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celiac Drugs Sales Market Share by Type (2019-2024)
6.3 Global Celiac Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Celiac Drugs Price by Type (2019-2024)
7 CELIAC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celiac Drugs Market Sales by Application (2019-2024)
7.3 Global Celiac Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Celiac Drugs Sales Growth Rate by Application (2019-2024)
8 CELIAC DRUGS MARKET SALES BY REGION
8.1 Global Celiac Drugs Sales by Region
8.1.1 Global Celiac Drugs Sales by Region
8.1.2 Global Celiac Drugs Sales Market Share by Region
8.2 Global Celiac Drugs Market Size by Region
8.2.1 Global Celiac Drugs Market Size by Region
8.2.2 Global Celiac Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Celiac Drugs Sales by Country
8.3.2 North America Celiac Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celiac Drugs Sales by Country
8.4.2 Europe Celiac Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celiac Drugs Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Celiac Drugs Market Size by Region
8.6.2 Asia Pacific Celiac Drugs Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Celiac Drugs Sales by Country
8.7.2 South America Celiac Drugs Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Celiac Drugs Sales by Region
8.8.2 Middle East and Africa Celiac Drugs Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 CELIAC DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Celiac Drugs by Region (2019-2024)
9.2 Global Celiac Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Celiac Drugs Production
9.4.1 North America Celiac Drugs Production Growth Rate (2019-2024)
9.4.2 North America Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Celiac Drugs Production
9.5.1 Europe Celiac Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Celiac Drugs Production (2019-2024)
9.6.1 Japan Celiac Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Celiac Drugs Production (2019-2024)
9.7.1 China Celiac Drugs Production Growth Rate (2019-2024)
9.7.2 China Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 ADMA Biologics
10.1.1 ADMA Biologics Celiac Drugs Basic Information
10.1.2 ADMA Biologics Celiac Drugs Product Overview
10.1.3 ADMA Biologics Celiac Drugs Product Market Performance
10.1.4 ADMA Biologics Business Overview
10.1.5 ADMA Biologics Celiac Drugs SWOT Analysis
10.1.6 ADMA Biologics Recent Developments
10.2 Amgen
10.2.1 Amgen Celiac Drugs Basic Information
10.2.2 Amgen Celiac Drugs Product Overview
10.2.3 Amgen Celiac Drugs Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen Celiac Drugs SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Anthera Pharmaceuticals
10.3.1 Anthera Pharmaceuticals Celiac Drugs Basic Information
10.3.2 Anthera Pharmaceuticals Celiac Drugs Product Overview
10.3.3 Anthera Pharmaceuticals Celiac Drugs Product Market Performance
10.3.4 Anthera Pharmaceuticals Celiac Drugs SWOT Analysis
10.3.5 Anthera Pharmaceuticals Business Overview
10.3.6 Anthera Pharmaceuticals Recent Developments
10.4 Bayer
10.4.1 Bayer Celiac Drugs Basic Information
10.4.2 Bayer Celiac Drugs Product Overview
10.4.3 Bayer Celiac Drugs Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Biogen
10.5.1 Biogen Celiac Drugs Basic Information
10.5.2 Biogen Celiac Drugs Product Overview
10.5.3 Biogen Celiac Drugs Product Market Performance
10.5.4 Biogen Business Overview
10.5.5 Biogen Recent Developments
10.6 BioLineRx
10.6.1 BioLineRx Celiac Drugs Basic Information
10.6.2 BioLineRx Celiac Drugs Product Overview
10.6.3 BioLineRx Celiac Drugs Product Market Performance
10.6.4 BioLineRx Business Overview
10.6.5 BioLineRx Recent Developments
10.7 Biotest
10.7.1 Biotest Celiac Drugs Basic Information
10.7.2 Biotest Celiac Drugs Product Overview
10.7.3 Biotest Celiac Drugs Product Market Performance
10.7.4 Biotest Business Overview
10.7.5 Biotest Recent Developments
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Celiac Drugs Basic Information
10.8.2 Bristol-Myers Squibb Celiac Drugs Product Overview
10.8.3 Bristol-Myers Squibb Celiac Drugs Product Market Performance
10.8.4 Bristol-Myers Squibb Business Overview
10.8.5 Bristol-Myers Squibb Recent Developments
10.9 Celgene
10.9.1 Celgene Celiac Drugs Basic Information
10.9.2 Celgene Celiac Drugs Product Overview
10.9.3 Celgene Celiac Drugs Product Market Performance
10.9.4 Celgene Business Overview
10.9.5 Celgene Recent Developments
10.10 Celimmune
10.10.1 Celimmune Celiac Drugs Basic Information
10.10.2 Celimmune Celiac Drugs Product Overview
10.10.3 Celimmune Celiac Drugs Product Market Performance
10.10.4 Celimmune Business Overview
10.10.5 Celimmune Recent Developments
10.11 F Hoffmann-La Roche
10.11.1 F Hoffmann-La Roche Celiac Drugs Basic Information
10.11.2 F Hoffmann-La Roche Celiac Drugs Product Overview
10.11.3 F Hoffmann-La Roche Celiac Drugs Product Market Performance
10.11.4 F Hoffmann-La Roche Business Overview
10.11.5 F Hoffmann-La Roche Recent Developments
10.12 ImmunogenX
10.12.1 ImmunogenX Celiac Drugs Basic Information
10.12.2 ImmunogenX Celiac Drugs Product Overview
10.12.3 ImmunogenX Celiac Drugs Product Market Performance
10.12.4 ImmunogenX Business Overview
10.12.5 ImmunogenX Recent Developments
10.13 Immunomedics
10.13.1 Immunomedics Celiac Drugs Basic Information
10.13.2 Immunomedics Celiac Drugs Product Overview
10.13.3 Immunomedics Celiac Drugs Product Market Performance
10.13.4 Immunomedics Business Overview
10.13.5 Immunomedics Recent Developments
10.14 ImmusanT
10.14.1 ImmusanT Celiac Drugs Basic Information
10.14.2 ImmusanT Celiac Drugs Product Overview
10.14.3 ImmusanT Celiac Drugs Product Market Performance
10.14.4 ImmusanT Business Overview
10.14.5 ImmusanT Recent Developments
10.15 Innovate Biopharmaceuticals
10.15.1 Innovate Biopharmaceuticals Celiac Drugs Basic Information
10.15.2 Innovate Biopharmaceuticals Celiac Drugs Product Overview
10.15.3 Innovate Biopharmaceuticals Celiac Drugs Product Market Performance
10.15.4 Innovate Biopharmaceuticals Business Overview
10.15.5 Innovate Biopharmaceuticals Recent Developments
10.16 Johnson and Johnson
10.16.1 Johnson and Johnson Celiac Drugs Basic Information
10.16.2 Johnson and Johnson Celiac Drugs Product Overview
10.16.3 Johnson and Johnson Celiac Drugs Product Market Performance
10.16.4 Johnson and Johnson Business Overview
10.16.5 Johnson and Johnson Recent Developments
10.17 Kedrion Biopharma
10.17.1 Kedrion Biopharma Celiac Drugs Basic Information
10.17.2 Kedrion Biopharma Celiac Drugs Product Overview
10.17.3 Kedrion Biopharma Celiac Drugs Product Market Performance
10.17.4 Kedrion Biopharma Business Overview
10.17.5 Kedrion Biopharma Recent Developments
10.18 LFB Group
10.18.1 LFB Group Celiac Drugs Basic Information
10.18.2 LFB Group Celiac Drugs Product Overview
10.18.3 LFB Group Celiac Drugs Product Market Performance
10.18.4 LFB Group Business Overview
10.18.5 LFB Group Recent Developments
10.19 Merck
10.19.1 Merck Celiac Drugs Basic Information
10.19.2 Merck Celiac Drugs Product Overview
10.19.3 Merck Celiac Drugs Product Market Performance
10.19.4 Merck Business Overview
10.19.5 Merck Recent Developments
10.20 Novartis
10.20.1 Novartis Celiac Drugs Basic Information
10.20.2 Novartis Celiac Drugs Product Overview
10.20.3 Novartis Celiac Drugs Product Market Performance
10.20.4 Novartis Business Overview
10.20.5 Novartis Recent Developments
11 CELIAC DRUGS MARKET FORECAST BY REGION
11.1 Global Celiac Drugs Market Size Forecast
11.2 Global Celiac Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celiac Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Celiac Drugs Market Size Forecast by Region
11.2.4 South America Celiac Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celiac Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Celiac Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Celiac Drugs by Type (2025-2032)
12.1.2 Global Celiac Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Celiac Drugs by Type (2025-2032)
12.2 Global Celiac Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Celiac Drugs Sales (K MT) Forecast by Application
12.2.2 Global Celiac Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Celiac Drugs
1.2 Key Market Segments
1.2.1 Celiac Drugs Segment by Type
1.2.2 Celiac Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELIAC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Celiac Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Celiac Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 CELIAC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Celiac Drugs Sales by Manufacturers (2019-2024)
3.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Celiac Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Celiac Drugs Sales Sites, Area Served, Product Type
3.6 Celiac Drugs Market Competitive Situation and Trends
3.6.1 Celiac Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Celiac Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELIAC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Celiac Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELIAC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELIAC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Celiac Drugs Sales Market Share by Type (2019-2024)
6.3 Global Celiac Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Celiac Drugs Price by Type (2019-2024)
7 CELIAC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Celiac Drugs Market Sales by Application (2019-2024)
7.3 Global Celiac Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Celiac Drugs Sales Growth Rate by Application (2019-2024)
8 CELIAC DRUGS MARKET SALES BY REGION
8.1 Global Celiac Drugs Sales by Region
8.1.1 Global Celiac Drugs Sales by Region
8.1.2 Global Celiac Drugs Sales Market Share by Region
8.2 Global Celiac Drugs Market Size by Region
8.2.1 Global Celiac Drugs Market Size by Region
8.2.2 Global Celiac Drugs Market Size Market Share by Region
8.3 North America
8.3.1 North America Celiac Drugs Sales by Country
8.3.2 North America Celiac Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Celiac Drugs Sales by Country
8.4.2 Europe Celiac Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Celiac Drugs Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Celiac Drugs Market Size by Region
8.6.2 Asia Pacific Celiac Drugs Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Celiac Drugs Sales by Country
8.7.2 South America Celiac Drugs Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Celiac Drugs Sales by Region
8.8.2 Middle East and Africa Celiac Drugs Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 CELIAC DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Celiac Drugs by Region (2019-2024)
9.2 Global Celiac Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Celiac Drugs Production
9.4.1 North America Celiac Drugs Production Growth Rate (2019-2024)
9.4.2 North America Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Celiac Drugs Production
9.5.1 Europe Celiac Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Celiac Drugs Production (2019-2024)
9.6.1 Japan Celiac Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Celiac Drugs Production (2019-2024)
9.7.1 China Celiac Drugs Production Growth Rate (2019-2024)
9.7.2 China Celiac Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 ADMA Biologics
10.1.1 ADMA Biologics Celiac Drugs Basic Information
10.1.2 ADMA Biologics Celiac Drugs Product Overview
10.1.3 ADMA Biologics Celiac Drugs Product Market Performance
10.1.4 ADMA Biologics Business Overview
10.1.5 ADMA Biologics Celiac Drugs SWOT Analysis
10.1.6 ADMA Biologics Recent Developments
10.2 Amgen
10.2.1 Amgen Celiac Drugs Basic Information
10.2.2 Amgen Celiac Drugs Product Overview
10.2.3 Amgen Celiac Drugs Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen Celiac Drugs SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Anthera Pharmaceuticals
10.3.1 Anthera Pharmaceuticals Celiac Drugs Basic Information
10.3.2 Anthera Pharmaceuticals Celiac Drugs Product Overview
10.3.3 Anthera Pharmaceuticals Celiac Drugs Product Market Performance
10.3.4 Anthera Pharmaceuticals Celiac Drugs SWOT Analysis
10.3.5 Anthera Pharmaceuticals Business Overview
10.3.6 Anthera Pharmaceuticals Recent Developments
10.4 Bayer
10.4.1 Bayer Celiac Drugs Basic Information
10.4.2 Bayer Celiac Drugs Product Overview
10.4.3 Bayer Celiac Drugs Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Biogen
10.5.1 Biogen Celiac Drugs Basic Information
10.5.2 Biogen Celiac Drugs Product Overview
10.5.3 Biogen Celiac Drugs Product Market Performance
10.5.4 Biogen Business Overview
10.5.5 Biogen Recent Developments
10.6 BioLineRx
10.6.1 BioLineRx Celiac Drugs Basic Information
10.6.2 BioLineRx Celiac Drugs Product Overview
10.6.3 BioLineRx Celiac Drugs Product Market Performance
10.6.4 BioLineRx Business Overview
10.6.5 BioLineRx Recent Developments
10.7 Biotest
10.7.1 Biotest Celiac Drugs Basic Information
10.7.2 Biotest Celiac Drugs Product Overview
10.7.3 Biotest Celiac Drugs Product Market Performance
10.7.4 Biotest Business Overview
10.7.5 Biotest Recent Developments
10.8 Bristol-Myers Squibb
10.8.1 Bristol-Myers Squibb Celiac Drugs Basic Information
10.8.2 Bristol-Myers Squibb Celiac Drugs Product Overview
10.8.3 Bristol-Myers Squibb Celiac Drugs Product Market Performance
10.8.4 Bristol-Myers Squibb Business Overview
10.8.5 Bristol-Myers Squibb Recent Developments
10.9 Celgene
10.9.1 Celgene Celiac Drugs Basic Information
10.9.2 Celgene Celiac Drugs Product Overview
10.9.3 Celgene Celiac Drugs Product Market Performance
10.9.4 Celgene Business Overview
10.9.5 Celgene Recent Developments
10.10 Celimmune
10.10.1 Celimmune Celiac Drugs Basic Information
10.10.2 Celimmune Celiac Drugs Product Overview
10.10.3 Celimmune Celiac Drugs Product Market Performance
10.10.4 Celimmune Business Overview
10.10.5 Celimmune Recent Developments
10.11 F Hoffmann-La Roche
10.11.1 F Hoffmann-La Roche Celiac Drugs Basic Information
10.11.2 F Hoffmann-La Roche Celiac Drugs Product Overview
10.11.3 F Hoffmann-La Roche Celiac Drugs Product Market Performance
10.11.4 F Hoffmann-La Roche Business Overview
10.11.5 F Hoffmann-La Roche Recent Developments
10.12 ImmunogenX
10.12.1 ImmunogenX Celiac Drugs Basic Information
10.12.2 ImmunogenX Celiac Drugs Product Overview
10.12.3 ImmunogenX Celiac Drugs Product Market Performance
10.12.4 ImmunogenX Business Overview
10.12.5 ImmunogenX Recent Developments
10.13 Immunomedics
10.13.1 Immunomedics Celiac Drugs Basic Information
10.13.2 Immunomedics Celiac Drugs Product Overview
10.13.3 Immunomedics Celiac Drugs Product Market Performance
10.13.4 Immunomedics Business Overview
10.13.5 Immunomedics Recent Developments
10.14 ImmusanT
10.14.1 ImmusanT Celiac Drugs Basic Information
10.14.2 ImmusanT Celiac Drugs Product Overview
10.14.3 ImmusanT Celiac Drugs Product Market Performance
10.14.4 ImmusanT Business Overview
10.14.5 ImmusanT Recent Developments
10.15 Innovate Biopharmaceuticals
10.15.1 Innovate Biopharmaceuticals Celiac Drugs Basic Information
10.15.2 Innovate Biopharmaceuticals Celiac Drugs Product Overview
10.15.3 Innovate Biopharmaceuticals Celiac Drugs Product Market Performance
10.15.4 Innovate Biopharmaceuticals Business Overview
10.15.5 Innovate Biopharmaceuticals Recent Developments
10.16 Johnson and Johnson
10.16.1 Johnson and Johnson Celiac Drugs Basic Information
10.16.2 Johnson and Johnson Celiac Drugs Product Overview
10.16.3 Johnson and Johnson Celiac Drugs Product Market Performance
10.16.4 Johnson and Johnson Business Overview
10.16.5 Johnson and Johnson Recent Developments
10.17 Kedrion Biopharma
10.17.1 Kedrion Biopharma Celiac Drugs Basic Information
10.17.2 Kedrion Biopharma Celiac Drugs Product Overview
10.17.3 Kedrion Biopharma Celiac Drugs Product Market Performance
10.17.4 Kedrion Biopharma Business Overview
10.17.5 Kedrion Biopharma Recent Developments
10.18 LFB Group
10.18.1 LFB Group Celiac Drugs Basic Information
10.18.2 LFB Group Celiac Drugs Product Overview
10.18.3 LFB Group Celiac Drugs Product Market Performance
10.18.4 LFB Group Business Overview
10.18.5 LFB Group Recent Developments
10.19 Merck
10.19.1 Merck Celiac Drugs Basic Information
10.19.2 Merck Celiac Drugs Product Overview
10.19.3 Merck Celiac Drugs Product Market Performance
10.19.4 Merck Business Overview
10.19.5 Merck Recent Developments
10.20 Novartis
10.20.1 Novartis Celiac Drugs Basic Information
10.20.2 Novartis Celiac Drugs Product Overview
10.20.3 Novartis Celiac Drugs Product Market Performance
10.20.4 Novartis Business Overview
10.20.5 Novartis Recent Developments
11 CELIAC DRUGS MARKET FORECAST BY REGION
11.1 Global Celiac Drugs Market Size Forecast
11.2 Global Celiac Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Celiac Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Celiac Drugs Market Size Forecast by Region
11.2.4 South America Celiac Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Celiac Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Celiac Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Celiac Drugs by Type (2025-2032)
12.1.2 Global Celiac Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Celiac Drugs by Type (2025-2032)
12.2 Global Celiac Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Celiac Drugs Sales (K MT) Forecast by Application
12.2.2 Global Celiac Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
